XPD Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-56327
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (94%), Rat (95%). Backed by our 100% Guarantee.
Applications
Immunocytochemistry/ Immunofluorescence
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to the following amino acid sequence: QEGEKLPFLGLALSSRKNLCIHPEVTPLRFGKDVDGKCHSLTASYVRAQYQHDTSLPHCRFYEEFDAHGREVPLPAGIYNLDDLK
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for XPD Antibody
Immunocytochemistry/ Immunofluorescence: XPD Antibody [NBP2-56327]
Immunocytochemistry/Immunofluorescence: XPD Antibody [NBP2-56327] - Staining of human cell line SiHa shows localization to nucleoplasm. Antibody staining is shown in green.Applications for XPD Antibody
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
0.25-2 ug/ml
Application Notes
ICC/IF Fixation Permeabilization: Use PFA/Triton X-100.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: XPD
Long Name
Xeroderma Pigmentosum D
Alternate Names
EM9, ERCC2
Gene Symbol
ERCC2
Additional XPD Products
Product Documents for XPD Antibody
Product Specific Notices for XPD Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...